Diabetes Mellitus and Elevated Copeptin Levels in Middle Age Predict Low Cognitive Speed after Long-Term Follow-Up.

Eva Tufvesson, Olle Melander, Lennart Minthon, Margaretha Persson, Peter Nilsson, Joachim Struck, Katarina Nägga

Research output: Contribution to journalArticlepeer-review

246 Downloads (Pure)

Abstract

Background/Aims: We examined the potential impact of vascular risk factors including copeptin - a robust surrogate marker of arginine vasopressin associated with the metabolic syndrome and diabetes risk - on future cognitive abilities in a population-based cohort. Methods: Participants (n = 933) were investigated using baseline data, including copeptin levels, and data collected 16 years later using the Mini-Mental State Examination (MMSE) and A Quick Test of Cognitive Speed (AQT). Results: Logistic regression showed that diabetes (OR, 1.86; p < 0.05) and higher copeptin levels (OR, 1.19; p < 0.05) were independently associated with an increased risk of low AQT performance. Conclusion: Prevalence of diabetes mellitus and elevated copeptin levels in middle age predict lower cognitive speed after long-term follow-up.
Original languageEnglish
Pages (from-to)67-76
JournalDementia and Geriatric Cognitive Disorders
Volume35
Issue number1-2
DOIs
Publication statusPublished - 2013

Subject classification (UKÄ)

  • Neurology

Fingerprint

Dive into the research topics of 'Diabetes Mellitus and Elevated Copeptin Levels in Middle Age Predict Low Cognitive Speed after Long-Term Follow-Up.'. Together they form a unique fingerprint.

Cite this